Literature DB >> 10146870

Strategic use of pharmacoeconomic research in early drug development and global pricing.

K Clemens1, L P Garrison, A Jones, F Macdonald.   

Abstract

Mesh：

Year:  1993        PMID： 10146870     DOI： 10.2165/00019053-199304050-00002

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  14 in total

1.  No price too high?

Authors:  A M Garber
Journal:  N Engl J Med       Date:  1992-12-03       Impact factor: 91.245

2.  Cost-of-illness studies: a major headache?

Authors:  M Drummond
Journal:  Pharmacoeconomics       Date:  1992-07       Impact factor: 4.981

3.  Cost-effectiveness analysis: obstacles to standardisation and its use in regulating pharmaceuticals.

Authors:  B R Luce
Journal:  Pharmacoeconomics       Date:  1993-01       Impact factor: 4.981

4.  Economic analysis as an aid to subsidisation decisions: the development of Australian guidelines for pharmaceuticals.

Authors:  D Henry
Journal:  Pharmacoeconomics       Date:  1992-01       Impact factor: 4.981

5.  Medicaid drug utilisation review under OBRA 1990: current issues and future directions.

Authors:  T R Fulda; S L Hass
Journal:  Pharmacoeconomics       Date:  1992-11       Impact factor: 4.981

6.  Guidelines for economic analysis of pharmaceutical products: a draft document for Ontario and Canada.

Authors:  A S Detsky
Journal:  Pharmacoeconomics       Date:  1993-05       Impact factor: 4.981

7.  Clinical decision making: from theory to practice. What's going on in Oregon?

Authors:  D M Eddy
Journal:  JAMA       Date:  1991-07-17       Impact factor: 56.272

Review 8.  The use of QALYs in health care decision making.

Authors:  G Loomes; L McKenzie
Journal:  Soc Sci Med       Date:  1989       Impact factor: 4.634

9.  Europe after 1992: implications for pharmaceuticals.

Authors:  M L Burstall
Journal:  Health Aff (Millwood)       Date:  1991       Impact factor: 6.301

10.  Postmarketing drug research and development.

Authors:  R J Townsend
Journal:  Drug Intell Clin Pharm       Date:  1987-01
View more
  10 in total

1.  Health economics in the Canadian pharmaceutical industry.

Authors:  L Assiff; M R Pollock; P Manzi; B Faienza; D Menon
Journal:  Pharmacoeconomics       Date:  1999-12       Impact factor: 4.981

Review 2.  Economic evaluations during early (phase II) drug development: a role for clinical trial simulations?

Authors:  D A Hughes; T Walley
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

3.  Emerging role of pharmacoeconomics in the research and development decision-making process.

Authors:  J A DiMasi; E Caglarcan; M Wood-Armany
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

4.  A new product pricing model using intracorporate market perceptions to extract the value of additional information.

Authors:  R S Woodward; L Amir; M A Schnitzler; D C Brennan
Journal:  Pharmacoeconomics       Date:  1998-07       Impact factor: 4.981

Review 5.  An introduction to Markov modelling for economic evaluation.

Authors:  A Briggs; M Sculpher
Journal:  Pharmacoeconomics       Date:  1998-04       Impact factor: 4.981

Review 6.  The effect of pharmacoeconomics on company research and development decisions.

Authors:  H Grabowski
Journal:  Pharmacoeconomics       Date:  1997-05       Impact factor: 4.981

Review 7.  Role of pharmacoeconomic analysis in R&D decision making: when, where, how?

Authors:  Paul Miller
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

8.  Early decision-analytic modeling - a case study on vascular closure devices.

Authors:  Alina Brandes; Moritz F Sinner; Stefan Kääb; Wolf H Rogowski
Journal:  BMC Health Serv Res       Date:  2015-10-27       Impact factor: 2.655

Review 9.  Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the Literature.

Authors:  Maarten J IJzerman; Hendrik Koffijberg; Elisabeth Fenwick; Murray Krahn
Journal:  Pharmacoeconomics       Date:  2017-07       Impact factor: 4.981

Review 10.  A Scoping Review of Different Methods of Assessing the Impact of New Medical Technologies at Early Stages of Development.

Authors:  Zahra Goudarzi; Shekoufeh Nikfar; Abbas Kebriaeezadeh; Reza Yousefi Zenouz; Akbar Abdollahi Asl; Nader Tavakoli
Journal:  Med J Islam Repub Iran       Date:  2021-10-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.